709 related articles for article (PubMed ID: 10481578)
1. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
[TBL] [Abstract][Full Text] [Related]
2. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of in vivo murine erythropoietic response to sodium orthovanadate.
Aguirre MV; Juaristi JA; Alvarez MA; Brandan NC
Chem Biol Interact; 2005 Sep; 156(1):55-68. PubMed ID: 16137666
[TBL] [Abstract][Full Text] [Related]
4. Murine erythropoietic impairment induced by paclitaxel: interactions of GATA-1 and erythroid Krüppel-like transcription factors, apoptotic related proteins and erythropoietin receptor.
Aguirre MV; Todaro JS; Juaristi JA; Brandan NC
Eur J Pharmacol; 2010 Jun; 636(1-3):42-51. PubMed ID: 20353770
[TBL] [Abstract][Full Text] [Related]
5. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
6. Hematotoxicity induced by paclitaxel: in vitro and in vivo assays during normal murine hematopoietic recovery.
Juaristi JA; Aguirre MV; Carmuega RJ; Romero-Benítez M; Alvarez MA; Brandan NC
Methods Find Exp Clin Pharmacol; 2001 May; 23(4):161-7. PubMed ID: 11676223
[TBL] [Abstract][Full Text] [Related]
7. Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3.
Aispuru GR; Aguirre MV; Aquino-Esperanza JA; Lettieri CN; Juaristi JA; Brandan NC
Cell Biol Int; 2008 Aug; 32(8):966-78. PubMed ID: 18485751
[TBL] [Abstract][Full Text] [Related]
8. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of splenic control of murine malaria: tissue culture studies of the erythropoietic interplay of spleen, bone marrow, and blood in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice.
Weiss L; Johnson J; Weidanz W
Am J Trop Med Hyg; 1989 Aug; 41(2):135-43. PubMed ID: 2774062
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
[TBL] [Abstract][Full Text] [Related]
11. Impaired response of polycythemic mice to erythropoietin induced by protein starvation imposed after hormone administration.
Barceló AC; Alippi RM; Boyer P; Olivera MI; Mide SM; Caro J; Bozzini CE
Stem Cells; 1993 Jul; 11(4):296-302. PubMed ID: 8401252
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic precursors in mice under erythropoietic stimulation and suppression.
Hara H; Ogawa M
Exp Hematol; 1977 Mar; 5(2):141-8. PubMed ID: 844518
[TBL] [Abstract][Full Text] [Related]
13. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
[TBL] [Abstract][Full Text] [Related]
14. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
Johnson CS; Cook CA; Furmanski P
Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
[TBL] [Abstract][Full Text] [Related]
15. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
16. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
17. Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide.
Biljanović-Paunović L; Milenković P; Kapa D; Pavlović-Kentera V
Exp Hematol; 1985 Jan; 13(1):67-73. PubMed ID: 3972018
[TBL] [Abstract][Full Text] [Related]
18. The erythropoietic effects of interleukin 6 and erythropoietin in vivo.
Ulich TR; del Castillo J; Yin SM; Egrie JC
Exp Hematol; 1991 Jan; 19(1):29-34. PubMed ID: 1989892
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
20. Retrovirally-produced erythropoietin effectively induces differentiation and proliferation of J2E erythroid cells.
Busfield SJ; Riches KJ; Sainsbury AJ; Rossi E; Garcia-Webb P; Klinken SP
Growth Factors; 1993; 9(2):87-97. PubMed ID: 8217220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
